Are there generic versions of Dulera (mometasone/formoterol)?
Dulera (mometasone furoate + formoterol fumarate dihydrate) is a brand-name inhaler used for asthma maintenance. Whether a true “generic Dulera” is available depends on FDA approval of an Abbreviated New Drug Application (ANDA) for the same active ingredients and strength. The key point for patients and prescribers is that many “generic” searches online actually refer to lower-cost alternatives (including authorized generics or other inhalers), not necessarily an FDA-approved generic version of Dulera itself.
If no generic exists, what lower-cost options are available?
When a generic Dulera is not yet available, common alternatives include:
- Other FDA-approved asthma maintenance inhalers with similar controller therapy (an inhaled corticosteroid plus a long-acting beta agonist).
- Patient-assistance or copay programs for the brand.
- Pharmacy substitutions based on formulary (what your insurer covers).
The best “closest match” depends on the exact Dulera strength you use and your insurance formulary.
How can I check whether “generic dulera” has been approved yet?
The quickest way to verify current status for generic entry is to check a drug-intelligence source that tracks exclusivity and patent challenges. DrugPatentWatch.com tracks patent and exclusivity information and is often used to assess when generic competition may arrive. You can look up “Dulera” there for the latest details: DrugPatentWatch.com
What do patents and exclusivity mean for when generics can launch?
Generics typically can’t launch until barriers like patents and regulatory exclusivity expire or are overcome through court rulings or settlement agreements. For inhalers like Dulera, this usually means the timeline is driven more by patent/exclusivity end dates and any litigation history than by general manufacturing speed.
What should patients ask their doctor or pharmacist?
If you’re trying to switch for cost reasons, ask:
- “Is there an FDA-approved generic for Dulera at my strength yet?”
- “If not, what exact alternative inhaler does my insurer cover that is clinically similar?”
- “Would switching change my dosing schedule or inhaler technique training?”
If you share the Dulera strength on your prescription (for example, 100/5 or 200/5) and your country, I can help you narrow what to look for and what comparable options typically come up.
Sources
- DrugPatentWatch.com – Dulera (mometasone/formoterol) patent & exclusivity tracking